Estimation of the lipophilicity of new anticancer and immunosuppressive 1,8-diazaphenothiazine derivatives

Journal of Chromatographic Science

Volumn 53, Issue 4, 2015, Pages 462-466

  Morak Młodawska, Beata ^a   Pluta, Krystian ^a   Jeleń, Małgorzata ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOSUPPRESSIVE AGENT; PHENOTHIAZINE DERIVATIVE;

CHEMICAL PHENOMENA; CHEMISTRY; REVERSED PHASE LIQUID CHROMATOGRAPHY;

ANTINEOPLASTIC AGENTS; CHROMATOGRAPHY, REVERSE-PHASE; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; IMMUNOSUPPRESSIVE AGENTS; PHENOTHIAZINES;

EID: 84941626703     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/bmu065     Document Type: Article

References (30)

1. Rutkowska, E., Pajak, K., Jóźwiak, K.; Lipophilicity-methods of determination and its role in medicinal chemistry; Acta Poloniae Pharmaceutica-Drug Research, (2013); 70: 1-18
2. Baguley, B.C., Finlay, G.J.; Derivatives of amsacrine: determinants required for high activity against Lewis lung carcinoma; Journal of the National Cancer Institute, (1988); 80: 195-199
3. Facchetti, I., Grandi, M., Cucchi, P., Geroni, C., Penco, S., Vigevani, A.; Influence of lipophilicity of anthracyclines in LoVo and LoVo/Dx human cell lines; Anti-Cancer Drug Design, (1991); 6: 385-397
4. Maliepaard, M., de Mol, N.J., Janssen, L.H.M., van der Neut, W., Verboom, W., Reinhoudt, D.N.; Role of lipophilicity in the in vitro antitumor activity of a series of new mitosene compounds; Anti Cancer Drug Design, (1992); 7: 415-425
5. Mazerska, Z., Augustin, E., Dziegielewski, J., Choldy, M.W., Konopa, J.; QSAR of acridines, III. Structure-Activity relationship for antitumor imidazoacridinones and intercorrelations between in vivo and in vitro tests; Anti-Cancer Drug Design, (1996); 11: 73-88
6. Kulig, K., Malawska, B.; Estimation of the lipophilicity of antiarrhythmic and antihypertensive active 1-substituted pyrrolidin-2-one and pyrrolidine derivatives; Biomedical Chromatography, (2003); 17: 318-324
7. Bajda, M., Bucki, A., Szlek, J., Szwaczyk, M., ͆wierczek, M., Malawska, B.; Determination of lipophilicity of a-(4-phenylpiperazine) derivatives of N-benzylamides using chromatographic and computational methods; Biomedical Chromatography, (2008); 22: 428-432
8. Bajda, M., Boryczka, S., Wietrzyk, J., Malawska, B.; Investigation of the lipophilicity of anticancer-Active tioquinoline derivatives; Biomedical Chromatography, (2007); 21: 123-127
9. Pluta, K., Nowak, M.; Study of the lipophilicity of the new diquinothiazines; Journal of Planar Chromatography-Modern TLC, (2006); 16: 157-160
10. Jeleń, M., Pluta, K., Morak-Mlodawska, B.; Determination of the lipophilicity parameters of new antiproliferative 8-10-substituted quinobenzothiazines by computational methods and RP TLC; Journal of Liquid Chromatography & Related Technologies, (2014); 37: 1373-1382
11. Zieba, A., Prus, W.; Determination of the lipophilicity of new azaphenothiazines by reversed-phase thin layer chromatography; Acta Chromatographica, (2009); 21: 369-378
12. Völgyi, G., Deák, K., Válmos, J., Valkó, K., Takács-Novák, K.; RPTLC determination of log P of structurally diverse neutral compounds; Journal of Planar Chromatography-Modern TLC, (2008); 21: 143-149
13. Vaštag, D., Perišić-Janjić, N., Tomić, J., Petrović, S.; Evaluation of the lipophilicity and prediction of biological activity of some N-cyclohexyl-N-substituted-2-phenylacetamide derivatives using RP-TLC; Journal of Planar Chromatography-Modern TLC, (2011); 24: 435-440
14. Skibiński, R., Slawik, T., Kaczkowska, M.; Reversed-phase TLC study of the lipophilicity of fourteen 1, 3-benzoxazol-2(3H)-one derivatives and comparison with isomeric 1, 2-benzisoxazol-3(2H)-one analogs; Journal of Planar Chromatography-Modern TLC, (2011); 24: 348-351
15. Petrilkova, E., Waisser, K.; A TLC study of the lipophilicity of new antimycobacterial active benzoxazine derivatives containing a thioxo group; Journal of Planar Chromatography-Modern TLC, (2011); 24: 196-200
16. Morak-Mlodawska, B., Pluta, K.; Acyl and sulfonyl derivatives of 10-Aminoalkyl-2, 7-diazaphenothiazins; Heterocycles, (2009); 78: 1289-1298
17. Zimecki, M., Artym, J., Kocieba, M., Pluta, K., Morak-Mlodawska, B., Jeleń, M.; The immunosuppressive activities of newly synthesized azaphenothiazines in human and mouse models; Cellular & Molecular Biology Letters, (2009); 14: 622-635
18. Morak-Mlodawska, B., Pluta, K., Matralis, A.N., Kourounakis, A.P.; Antioxidant activity of newly synthesized 2, 7-diazaphenothiazines; Archive der Pharmazie, (2010); 343: 268-273
19. Morak-Mlodawska, B., Jeleń, M., Pluta, K.; Determination of the lipophilicity parameters Log Pcalcd, Rm0 and log Ptlc of new anticancer acylaminoalkyl-And sulfonylaminoalkylazaphenothiazines by computational methods and reversed-phase thin-layer chromatography; Journal of Liquid Chromatography & Related Technologies, (2011); 34: 375-387
20. Pluta, K., Morak-Mlodawska, B., Zimecki, M., Jeleń, M., Artym, J., Kocieba, M. Polish Patent Appl. P.404629 (2013)
21. Morak-Mlodawska, B., Suwińska, K., Pluta, K., Jeleń, M.; 10-(30-Nitro-40-pyridyl)-1, 8-diazaphenothiazine as the double Smiles rearrangement product; Journal of Molecular Structure, (2012); 1015: 94-98
22. Mannhold, R., Cruciani, G., Dross, K., Rekker, R.; Multivariate analysis of experimental and computational descriptors of molecular lipophilicity; Journal of Computer-Aided Molecular Design, (1998); 12: 573-581
23. Bodor, N., Gabanyi, Z., Wong, C.K.; A new method for the estimation of partition coefficient; Journal of the American Chemical Society, (1989); 111: 3783-3786
24. VCCLAB, Virtual Computational Chemistry Laboratory. (2012). http://www.vcclab.org
25. ClogP (CS Chem 3D Ultra 7.0, Molecular Modeling and Analysis) distributed by CambridgeSoft
26. Biaggi, G.L., Barbaro, A.M., Sapone, A.; Determination of the lipophilicity by means of reversed-phase. I: basic aspects and relationship between slope and intercept of TLC equitions; Journal of Chromatography A, (1994); 662: 341-361
27. Motohashi, N., Kawase, M., Saito, S., Sakagami, H.; Antitumor potential and possible targets of phenothiazine-related compounds; Current Drug Targets, (2000); 1: 237-245
28. Jeleń, M., Pluta, K., Zimecki, M., Morak-Mlodawska, B., Artym, J., Kocieba, M.; Synthesis and selected immunological properties of substituted quino[3, 2-b]benzo[1, 4]thiazines; European Journal of Medicinal Chemistry, (2013); 63: 444-456
29. Mannhold, R., Dross, K.; Calculation procedures for molecular lipophilicity: a comparative study; Quantitative Structure-Activity Relationships, (1996); 15: 403-409
30. Morak, B., Pluta, K.; RP TLC determination of the lipophilicity of new 10-substituted 2, 7-diazaphenothiazines; Journal of Liquid Chromatography & Related Technologies, (2008); 31: 611-618